IBS CAPITAL LLC 13D/13G Filings for AgeX Therapeutics, Inc. (AGE)

IBS CAPITAL LLC 13D and 13G filings for AgeX Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-10-16
4:35 pm
Sale
2020-10-08 13G AgeX Therapeutics, Inc.
AGE
IBS CAPITAL LLC 53,561
4.998%
-23,543decrease
(-30.53%)
Filing